Free Trial
NASDAQ:SGRY

Surgery Partners (SGRY) Stock Price, News & Analysis

$32.02
+1.27 (+4.13%)
(As of 07/26/2024 ET)
Today's Range
$30.88
$32.21
50-Day Range
$23.04
$30.75
52-Week Range
$22.05
$39.64
Volume
1.40 million shs
Average Volume
982,813 shs
Market Capitalization
$4.07 billion
P/E Ratio
34.51
Dividend Yield
N/A
Price Target
$40.14

Surgery Partners MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
Upside/​Downside
25.4% Upside
$40.14 Price Target
Short Interest
Bearish
16.94% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.47mentions of Surgery Partners in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$324,240 Sold Last Quarter
Proj. Earnings Growth
28.41%
From $0.88 to $1.13 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.93 out of 5 stars

Medical Sector

425th out of 936 stocks

General Medical & Surgical Hospitals Industry

4th out of 5 stocks

SGRY stock logo

About Surgery Partners Stock (NASDAQ:SGRY)

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

SGRY Stock Price History

SGRY Stock News Headlines

Surgery Partners Inc
Ardent Health Partners Inc
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
Surgery Partners’ Growth Prospects Bolster Buy Rating
Surgery Partners Inc.
See More Headlines
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
N/A
Current Symbol
NASDAQ:SGRY
Employees
13,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$40.14
High Stock Price Target
$50.00
Low Stock Price Target
$31.00
Potential Upside/Downside
+25.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.86
Research Coverage
7 Analysts

Profitability

Net Income
$-11,900,000.00
Pretax Margin
5.87%

Debt

Sales & Book Value

Annual Sales
$2.74 billion
Cash Flow
$1.94 per share
Book Value
$23.99 per share

Miscellaneous

Free Float
124,171,000
Market Cap
$4.07 billion
Optionable
Optionable
Beta
2.78
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

SGRY Stock Analysis - Frequently Asked Questions

How have SGRY shares performed this year?

Surgery Partners' stock was trading at $31.99 at the start of the year. Since then, SGRY shares have increased by 0.1% and is now trading at $32.02.
View the best growth stocks for 2024 here
.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) posted its earnings results on Tuesday, May, 7th. The company reported $0.06 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.02. The business had revenue of $717.40 million for the quarter, compared to the consensus estimate of $707.66 million. Surgery Partners had a trailing twelve-month return on equity of 3.65% and a net margin of 0.02%.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees.

Who are Surgery Partners' major shareholders?

Surgery Partners' top institutional shareholders include Bank of New York Mellon Corp (0.27%), Raymond James & Associates (0.05%), Tranquility Partners LLC (0.05%) and Harbor Capital Advisors Inc. (0.04%). Insiders that own company stock include Andrew T Kaplan, Jason Eric Evans, Jennifer Baldock, Wayne S Deveydt, David T Doherty, Bradley R Owens, Brent Turner, Harrison R Bane, Laura L Brocklehurst, George Goodwin, Marissa Brittenham, Danielle Burkhalter, Teresa Deluca and Anthony Taparo.
View institutional ownership trends
.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO) and Xilinx (XLNX).

This page (NASDAQ:SGRY) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners